<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PubTator</source><date>2020-12-04</date><key>BioC.key</key>
<document><id>24004819</id><passage><infon key="type">title</infon><offset>0</offset><text>Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity.</text><annotation id="0"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="31" length="16"/><text>cyclooxygenase 2</text></annotation></passage><passage><infon key="type">abstract</infon><offset>139</offset><text>INTRODUCTION: Systemic inhibition of the inflammatory enzyme cyclooxygenase (COX) 2 decreases the risk of breast cancer and its recurrence. However, the biology of COX-2 in the multicellular tumor microenvironment is poorly defined. METHODS: Mammary tumor onset and multiplicity were examined in ErbB2 transgenic mice that were deficient in mammary epithelial cell COX-2 (COX-2(MEC)KO) compared to wild type (WT) mice. Tumors were analyzed, by real time PCR, immune-staining and flow cytometry, for proliferation, apoptosis, angiogenesis and immune microenvironment. Lentiviral shRNA delivery was used to knock down (KD) COX-2 in ErbB2-transformed mouse breast cancer cells (COX-2KD), and growth as orthotopic tumors was examined in syngenic recipient mice, with or without depletion of CD8+ immune cells. RESULTS: Mammary tumor onset was delayed, and multiplicity halved, in COX-2(MEC)KO mice compared to WT. COX-2(MEC)KO tumors showed decreased expression of Ki67, a proliferation marker, as well as reduced VEGFA, its receptor VEGFR2, endothelial NOS and the vascular endothelial marker CD31, indicating reduced tumor vascularization. COX-2(MEC)KO tumors contained more CD4+ T helper (Th) cells and CD8+ cytotoxic immune cells (CTL) consistent with increased immune surveillance. The ratio of Th markers Tbet (Th1) to GATA3 (Th2) was higher, and levels of Retnla, a M2 macrophage marker, lower, in COX-2(MEC)KO tumor infiltrating leukocytes compared to WT, suggesting a prevalence of pro-immune Th1 over immune suppressive Th2 lymphocytes, and reduced macrophage polarization to the immune suppressive M2 phenotype. Enhanced immune surveillance in COX-2(MEC)KO tumors was coincident with increased intratumoral CXCL9, a T cell chemoattractant, and decreased expression of T lymphocyte co-inhibitory receptors CTLA4 and PD-1, as well as PD-L1, the ligand for PD-1. PD-L1 was also decreased in IFNgamma-treated COX-2KD mouse mammary cancer cells in vitro and, compared to control cells, growth of COX-2KD cells as orthotopic tumors in immune competent mice was markedly suppressed. However, robust growth of COX-2KD tumor cells was evident when recipients were depleted of CD8+ cells. CONCLUSIONS: The data strongly support that, in addition to its angiogenic function, tumor cell COX-2 suppresses intratumoral cytotoxic CD8+ immune cell function, possibly through upregulation of immune checkpoints, thereby contributing to tumor immune escape. COX-2 inhibition may be clinically useful to augment breast cancer immunotherapy.</text><annotation id="1"><infon key="code">000</infon><infon key="NCBI Gene identifier">19225</infon><infon key="type">Gene</infon><location offset="200" length="22"/><text>cyclooxygenase (COX) 2</text></annotation><annotation id="2"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="303" length="5"/><text>COX-2</text></annotation><annotation id="3"><infon key="NCBI Gene identifier">13866</infon><infon key="type">Gene</infon><location offset="435" length="5"/><text>ErbB2</text></annotation><annotation id="4"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="504" length="5"/><text>COX-2</text></annotation><annotation id="5"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="511" length="5"/><text>COX-2</text></annotation><annotation id="6"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="760" length="5"/><text>COX-2</text></annotation><annotation id="7"><infon key="NCBI Gene identifier">13866</infon><infon key="type">Gene</infon><location offset="769" length="5"/><text>ErbB2</text></annotation><annotation id="8"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="814" length="5"/><text>COX-2</text></annotation><annotation id="9"><infon key="code">333</infon><infon key="NCBI Gene identifier">12525,12526</infon><infon key="type">Gene</infon><location offset="926" length="3"/><text>CD8</text></annotation><annotation id="10"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="1015" length="5"/><text>COX-2</text></annotation><annotation id="11"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="1049" length="5"/><text>COX-2</text></annotation><annotation id="12"><infon key="NCBI Gene identifier">17345</infon><infon key="type">Gene</infon><location offset="1100" length="4"/><text>Ki67</text></annotation><annotation id="13"><infon key="NCBI Gene identifier">22339</infon><infon key="type">Gene</infon><location offset="1149" length="5"/><text>VEGFA</text></annotation><annotation id="14"><infon key="NCBI Gene identifier">16542</infon><infon key="type">Gene</infon><location offset="1169" length="6"/><text>VEGFR2</text></annotation><annotation id="15"><infon key="NCBI Gene identifier">18127</infon><infon key="type">Gene</infon><location offset="1177" length="15"/><text>endothelial NOS</text></annotation><annotation id="16"><infon key="NCBI Gene identifier">18613</infon><infon key="type">Gene</infon><location offset="1229" length="4"/><text>CD31</text></annotation><annotation id="17"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="1277" length="5"/><text>COX-2</text></annotation><annotation id="18"><infon key="NCBI Gene identifier">12504</infon><infon key="type">Gene</infon><location offset="1312" length="3"/><text>CD4</text></annotation><annotation id="19"><infon key="code">333</infon><infon key="NCBI Gene identifier">12525,12526</infon><infon key="type">Gene</infon><location offset="1341" length="3"/><text>CD8</text></annotation><annotation id="20"><infon key="NCBI Gene identifier">57765</infon><infon key="type">Gene</infon><location offset="1446" length="4"/><text>Tbet</text></annotation><annotation id="21"><infon key="NCBI Gene identifier">14462</infon><infon key="type">Gene</infon><location offset="1460" length="5"/><text>GATA3</text></annotation><annotation id="22"><infon key="NCBI Gene identifier">57262</infon><infon key="type">Gene</infon><location offset="1498" length="6"/><text>Retnla</text></annotation><annotation id="23"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="1540" length="5"/><text>COX-2</text></annotation><annotation id="24"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="1790" length="5"/><text>COX-2</text></annotation><annotation id="25"><infon key="NCBI Gene identifier">17329</infon><infon key="type">Gene</infon><location offset="1853" length="5"/><text>CXCL9</text></annotation><annotation id="26"><infon key="code">222</infon><infon key="NCBI Gene identifier">12477,18566,60533</infon><infon key="type">Gene</infon><location offset="1914" length="36"/><text>T lymphocyte co-inhibitory receptors</text></annotation><annotation id="27"><infon key="NCBI Gene identifier">12477</infon><infon key="type">Gene</infon><location offset="1951" length="5"/><text>CTLA4</text></annotation><annotation id="28"><infon key="NCBI Gene identifier">18566</infon><infon key="type">Gene</infon><location offset="1961" length="4"/><text>PD-1</text></annotation><annotation id="29"><infon key="NCBI Gene identifier">60533</infon><infon key="type">Gene</infon><location offset="1978" length="5"/><text>PD-L1</text></annotation><annotation id="30"><infon key="NCBI Gene identifier">18566</infon><infon key="type">Gene</infon><location offset="2000" length="4"/><text>PD-1</text></annotation><annotation id="31"><infon key="NCBI Gene identifier">60533</infon><infon key="type">Gene</infon><location offset="2006" length="5"/><text>PD-L1</text></annotation><annotation id="32"><infon key="code">000</infon><infon key="NCBI Gene identifier">15978</infon><infon key="type">Gene</infon><location offset="2034" length="8"/><text>IFNgamma</text></annotation><annotation id="33"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="2051" length="5"/><text>COX-2</text></annotation><annotation id="34"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="2137" length="5"/><text>COX-2</text></annotation><annotation id="35"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="2248" length="5"/><text>COX-2</text></annotation><annotation id="36"><infon key="code">333</infon><infon key="NCBI Gene identifier">12525,12526</infon><infon key="type">Gene</infon><location offset="2313" length="3"/><text>CD8</text></annotation><annotation id="37"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="2421" length="5"/><text>COX-2</text></annotation><annotation id="38"><infon key="code">333</infon><infon key="NCBI Gene identifier">12525,12526</infon><infon key="type">Gene</infon><location offset="2461" length="3"/><text>CD8</text></annotation><annotation id="39"><infon key="NCBI Gene identifier">19225</infon><infon key="type">GENERIF</infon><location offset="2586" length="5"/><text>COX-2</text></annotation></passage></document>
</collection>
